Combinatorial selection of oligonucleotide aptamers

• US 6,423,493 B1
• Filed: 10/25/1999
• Issued: 07/23/2002
• Est. Priority Date: 10/26/1998
• Status: Expired due to Term

• Current Assignee: Board of Regents of the University of Texas System (University of Texas System)
• Original Assignee: Board of Regents of the University of Texas System (University of Texas System)
• Inventors: King, David J., Gorenstein, David G., Ventura, Daniel A., Brasier, Allan R.
• Primary Examiner(s): Ponnaluri, Padmashri
• Assistant Examiner(s): Friend, Thomas
• Application Number:
  US09/425,798
• Time in Patent Office: 1,002 Days
• Field of Search: 536/23.1, 514/44, 435/6, 435/91.2, 435/7.1, 435/DIG.47
• US Class Current: 506/9
• CPC Class Codes: A61K 38/00 Medicinal preparations containing peptides peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00
• CPC Class Codes: C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
• CPC Class Codes: C12N 15/1048 SELEX
• CPC Class Codes: C12N 15/115 Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
• CPC Class Codes: C12N 2310/313 Phosphorodithioates
• CPC Class Codes: C12N 2310/315 Phosphorothioates
• CPC Class Codes: C40B 40/00 Libraries per se, e.g. arrays, mixtures

Abstract

A random combinatorial selection method is disclosed for the construction of oligonucleotide aptamers in which nuclease resistance is conferred by the inclusion of modified nucleotides. The modified nucleotides are incorporated during PCR amplification to form achiral modified oligonucleotides. Thio-substituted aptamers are provided that bind tightly to the nuclear factor for human IL6 (NF-IL6).

Claims

1. A method of identifying an aptamer comprising the steps of:

(a) synthesizing a random phosphodiester oligonucleotide combinatorial library wherein constituent oligonucleotides comprise at least a set of 5′ and

3′

PCR primer nucleotide sequences flanking a randomized nucleotide sequence;

(b) amplifying the library enzymatically using a mix of four nucleotides, wherein one or more of the nucleotides comprises a mix of unmodified and thiophosphate-modified nucleotides, to form a partially thiophosphate-modified oligonucleotide combinatorial library;

(c) contacting the partially thiophosphate-modified oligonucleotide combinatorial library with a target molecule and isolating a subset of oligonucleotides binding to the target molecule;

(d) amplifying the subset of binding oligonucleotides enzymatically using a mix of four nucleotides, wherein at least a portion of at least one nucleotide is thiophosphate-modified, to form a thiophosphate-modified oligonucleotide sub-library; and

(e) repeating steps (c)-(d) iteratively with increased stringency of the contacting step between each iteration until at least one aptamer comprising a thiophosphate-modified oligonucleotide population of defined sequence is obtained.

2. The method of claim 1, wherein the modified nucleotide comprises a phosphorothioate.

3. The method of claim 1, wherein the modified nucleotide comprises a phosphorodithioate.

4. The method of claim 1, wherein the modified nucleotide is selected from the group consisting of dATP(α

S), dTTP(α

S), dCTP(α

S) and dGTP(α

S).

5. The method of claim 1, wherein no more than three adjacent phosphate sites are replaced with phosphorothioate groups.

6. The method of claim 1, wherein at least a portion of non-adjacent phosphate sites are replaced with phosphorothioate groups.

7. The method of claim 1, wherein no more than three adjacent phosphate sites are replaced with phosphorodithioate groups.

8. The method of claim 1, wherein at least a portion of non-adjacent phosphate sites are replaced with phosphorodithioate groups.

9. The method of claim 1, wherein the target is a nucleic acid binding protein.

10. The method of claim 1, wherein the target is NF-IL6.

11. A method of identifying a set of aptamers containing an optimal composition of thiophosphate-modified nucleotides such that the aptamers bind with high affinity to a target molecule, and have increased resistance to nuclease degradation, said method comprising the steps of:

(a) synthesizing a random partially thiophosphate-modified oligonucleotide combinatorial library wherein at least a portion of the oligonucleotide phosphate groups are thiophosphate-modified nucleotides, and where no more than three of the four different nucleotides are substituted on the 5′

-phosphate positions by 5′

-thiophosphates in each synthesized oligonucleotide are thiophosphate-modified nucleotides;

(b) amplifying the library enzymatically using a mix of four nucleotides, wherein one or more of the nucleotides comprises a mix of unmodified and thiophosphate-modified nucleotides, whereby no more than three adjacent phosphate sites in each amplified oligonucleotide are thiophosphate-modified nucleotides;

(c) contacting the amplified library with a target molecule under conditions favorable for binding of a binding oligonucleotide with said target molecule;

(d) isolating a subset of binding oligonucleotides from the library, that bind with higher affinity to the target molecule relative to the original amplified library; and

(e) amplifying the subset of binding oligonucleotides enzymatically using a mix of four nucleotides, wherein one or more of the nucleotides comprises a mix of unmodified and thiophosphate-modified nucleotides.

12. The method of claim 11, further comprising the step of:

(f) repeating steps (c)-(e) iteratively, whereby an enriched subset of oligonucleotides binding with higher affinity to the target molecule relative to the original amplified subset, is isolated after each cycle.

13. The method of claim 12, whereby each iteration is performed under conditions of increased stringency in the contacting step until a subset of high affinity binding oligonucleotides is identified.

14. The method of claim 11, whereby synthesis of the combinatorial library is done using constituent oligonucleotides comprising at least a set of 5′

and 3′

PCR primer nucleotide sequences flanking a randomized nucleotide sequence.

15. The method of claim 11, whereby the subset of amplified oligonucleotides is cloned and where individual thiophosphate-modified oligonucleotides that bind to the target are isolated and sequenced.

16. The method of claim 15, whereby the isolated aptamer is screened relative to its respective non-modified oligonucleotide, to possess:

(a) increased affinity for the target, and

(b) increased stability with respect to nuclease degradation.

17. The method of claim 16, whereby the thiophosphate comprises a phosphorodithioate.

18. The method of claim 16, whereby the thiophosphate comprises a phosphorothioate or phosphorodithioate.

19. A method of identifying an aptamer that specifically recognizes NF-IL6, comprising the steps of:

(a) synthesizing a random phosphodiester oligonucleotide combinatorial library wherein constituent oligonucleotides comprise at least a set of 5′ and

3′

PCR primer nucleotide sequences flanking a randomized nucleotide sequence;

(b) amplifying the library enzymatically using a mix of four nucleotides, wherein one or more of the nucleotides comprises a mix of unmodified and triphosphate (alpha-S) modified nucleotides to form a thiophosphate-modified oligonucleotide combinatorial library;

(c) contacting the thiophosphate-modified oligonucleotide combinatorial library with an NF-IL6 target molecule and isolating a subset of oligonucleotides binding to the NF-IL6 target molecule;

(d) amplifying the subset of binding oligonucleotides enzymatically using a mix of four nucleotide nucleotides, wherein a portion of at least one and no more than three of the nucleotide nucleotides in the mix is a nucleotide triphosphate, to form a thiophosphate-modified oligonucleotide sub-library; and

(e) repeating steps contacting and amplifying the oligonucleotides iteratively with increased stringency of the contacting step between each iteration until at least one aptamer comprising a thiophosphate-modified oligonucleotide population of defined sequence and site of thiophosphate substitution is obtained and only a portion of the oligonucleotide is substituted.

20. The method of claim 19, whereby the thiophosphate comprises a phosphorodithioate.

21. The method of claim 19, whereby the thiophosphate comprises a phosphorothioate and phosphorodithioate.